Centene Corporation (CNC) Dividend Safety Gauge & 10-Year DRIP Compounder

The Roarable RQD score is 63 out of 100, graded C, with the verdict "Roarable Hold — Fair / Balanced Risk-Reward" (per the Roarable RQD rating). The five pillars are: Fundamental Cash Engine at 11/20, where ROIC of -31% is weak while FCF yield of 12.72% is strong; Whale 13F Flow at 16/20, reflecting institutional accumulation and options positioning; Insider Conviction at 12/20, based on SEC Form 4 and Congressional PTR cluster flow; Macro Regime Fit at 14/20, with beta of 0.94 and sector sensitivity; and Forensic Balance Sheet at 10/20, with Altman Z 2.52, Piotroski F 6/9, and Debt/Equity 0.87 (per the Roarable RQD rating).

For a prospective investor, the upside drivers are the high FCF yield and the positive institutional flow signal. The valuation tradeoffs are notable: forward P/E is 36 while trailing EPS is -13.48, and ROIC is -31%, so the cash-generation case rests on FCF rather than accounting earnings. The balance sheet is the weakest pillar relative to its cap, and insider conviction is middling. The overall verdict is balanced rather than decisive, which is consistent with a mixed set of signals. This is an analytical framing, not personalized advice.

Centene Corporation (CNC) is a NYSE-listed issuer in the Health Care sector and the Medical Specialities industry (per the company profile). The source data does not describe its products, customers, or revenue model beyond sector and industry classification. Reported revenue, however, is shown in the financial history below.

Per the SEC financials, FY 2025 swung to an operating loss and net loss after a profitable FY 2024. Reported margins are gross 8.1%, operating -4.4%, and net -3.8% (per the market data). ROIC is -31% and the Altman Z-Score is 2.52, with Piotroski F-Score 6/9 (per the Roarable RQD rating). Debt/Equity is 0.87 (per the Roarable RQD rating), and FY 2025 FCF of $4321.0M is positive, while FY 2024 FCF was negative.

Recent headlines (per the news and catalysts feed) are all tagged as market wire items with a YELLOW signal. They include a report that the stock is trading up, a report that the stock is approaching its 52-week high on faster-than-expected earnings recovery, and a preview of the Q3 2026 quarter that frames 2027 as a bridge. The feed items are aggregator summaries and do not provide specific fundamental detail. The butterfly supply-chain graph shows no supply-chain links and no proprietary signals.

• What drove the swing from FY 2024 net income of $3305.0M to FY 2025 net loss of $-6674.0M, and is the reported EPS of N/A consistent with the net income line?
• Why is trailing P/E and EV/EBITDA unavailable while forward P/E is 36, and what earnings base underlies that forward figure?
• What explains the FY 2023 cash figure being N/A while debt was $39338.7M, and how has debt declined to $17351.0M by FY 2025?
• What are the company's revenue sources and product mix, since the source data gives only sector classification?
• What institutional, insider, or analyst positioning exists, given that holder and analyst data are absent?